Proglikemia Sp. z o.o. operates in the healthcare and medical-technology distribution and support space, with activity associated with continuous glucose monitoring solutions for diabetes management in Poland. The companys commercial scope centers on enabling patient and provider access to CGM systems, supporting product availability, fulfillment flows, and customer service processes typically required for regulated medical-device programs. The operational model includes handling of information and service processes connected to device use and user support, aligned to requirements for secure processing and compliant service delivery in healthcare contexts. Key brand and asset association is linked to the Dexcom CGM product ecosystem used in diabetes self-management, and the companys role supports market development, user onboarding support, and broader adoption of CGM in Poland. Geographic reach is Poland-focused, serving the local healthcare market and end users within national distribution and support structures. Strategic focus is positioned around supporting modern diabetes-care pathways by expanding access to CGM technology and maintaining service processes that facilitate safe, reliable, and scalable patient support and device lifecycle handling within the Polish market.
Headquarters
Ul. Skierniewicka 16/20
Warsaw; Mazowieckie;
Postal Code: 01-230
Contact Details: Purchase the Proglikemia Sp. z o.o. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service